Monitor Personalis shareholder vote and HSR clearance timeline. The exchange ratio is sensitive to TEM's stock price, if TEM trades below $48.42, the ratio fixes at 0.3356, capping dilution. A drop below $46.00 gives Personalis a termination right, creating a floor for TEM stock during the pendency of the deal.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 21 $48.98entry
- T+1 · 4mo ago −4.12%α −4.01% · $46.96
- T+5 · 4mo ago −12.39%α −11.16% · $42.91
- T+20 · 3mo ago +0.78%α −1.79% · $49.36
- T+60 · 5w ago +39.28%α +35.31% · $68.22
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Tempus AI (TEM) has entered into a definitive merger agreement to acquire Personalis, Inc. in a stock-for-stock transaction valued at an implied $16.25 per Personalis share, with Tempus retaining the option to pay cash for up to 50% of shares. The deal brings Personalis's molecular residual disease (MRD) technology into Tempus's AI-enabled precision oncology platform, targeting a $20B market opportunity. Closing is expected by April 2027, subject to Personalis shareholder approval, HSR clearance, and other customary conditions.
Key Financial Metrics
Key Facts
- Per-share consideration: $16.25 cash option or stock based on floating exchange ratio with floor at $48.42 TEM stock price
- Termination fee: ~$76.8M payable by either party under specified conditions
- Personalis has a termination right if TEM stock falls below $46.00
- Transaction structured as tax-free reorganization under Section 368(a) of the Code
- Expected closing by April 20, 2027, with automatic six-month extensions possible
Financial Impact
Transaction valued at approximately $1.5B enterprise value (net of Tempus's existing stake). Tempus will issue stock consideration with potential cash component up to 50% of shares.
Risk Factors
- Personalis shareholder approval not obtained
- Regulatory delays or antitrust conditions under HSR Act
- TEM stock price decline below $46.00 triggering Personalis termination right
- Integration risk combining MRD technology with Tempus platform
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001193125-26-309081 |
| Document: 0001193125-26-309081-index-headers.html | 0001193125-26-309081 |
| Document: 0001193125-26-309081-index.html | 0001193125-26-309081 |
| Document: 0001193125-26-309081.txt | 0001193125-26-309081 |
Track record
45 reports on TEM
7 of 9 bullish or bearish reports moved the stock their way by T+60. Best: +53.09% at T+60 after the Jul 30, 2026 report. 16 of 17 went positive at some point.
Filters
- Nov 9, 20267d ago Press Release Neutral 3/10 Entry $80.54 Now $64.76 −19.59% settles Feb 8
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $76.05 Now $64.76 −14.85% settles Feb 4
- Nov 4, 202612d ago Insider Cluster Neutral 3/10 Entry $70.43 Now $64.76 −8.05% settles Feb 3
- Nov 2, 202614d ago 144 Neutral 1/10 Entry $77.80 Now $64.76 −16.76% settles Feb 1
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $78.48 Now $64.76 −17.48% settles Jan 29
- Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $77.84 Now $64.76 −16.80% settles Jan 27
- Oct 28, 202619d ago Institutional Cluster Neutral 3/10 Entry $76.61 Now $64.76 −15.47% settles Jan 26
- Oct 27, 202620d ago 144 Neutral 3/10 Entry $76.61 Now $64.76 −15.47% settles Jan 26
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $67.62 Now $64.76 −4.22% settles Jan 21
- Oct 22, 202626d ago EFFECT Neutral 4/10 Entry $63.81 Now $64.76 +1.49% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers